133 related articles for article (PubMed ID: 20395019)
21. Design, synthesis, biological evaluation and molecular modeling of 1,3,4-oxadiazoline analogs of combretastatin-A4 as novel antitubulin agents.
Hu Y; Lu X; Chen K; Yan R; Li QS; Zhu HL
Bioorg Med Chem; 2012 Jan; 20(2):903-9. PubMed ID: 22192936
[TBL] [Abstract][Full Text] [Related]
22. Regioselective Suzuki coupling of dihaloheteroaromatic compounds as a rapid strategy to synthesize potent rigid combretastatin analogues.
Theeramunkong S; Caldarelli A; Massarotti A; Aprile S; Caprioglio D; Zaninetti R; Teruggi A; Pirali T; Grosa G; Tron GC; Genazzani AA
J Med Chem; 2011 Jul; 54(14):4977-86. PubMed ID: 21696175
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, biological evaluation and molecular modeling of 1,2,3-triazole analogs of combretastatin A-1.
Akselsen OW; Odlo K; Cheng JJ; Maccari G; Botta M; Hansen TV
Bioorg Med Chem; 2012 Jan; 20(1):234-42. PubMed ID: 22137934
[TBL] [Abstract][Full Text] [Related]
24. The resveratrol analogue trimethoxystilbene inhibits cancer cell growth by inducing multipolar cell mitosis.
Traversi G; Fiore M; Percario Z; Degrassi F; Cozzi R
Mol Carcinog; 2017 Mar; 56(3):1117-1126. PubMed ID: 27739192
[TBL] [Abstract][Full Text] [Related]
25. 1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin.
Odlo K; Hentzen J; dit Chabert JF; Ducki S; Gani OA; Sylte I; Skrede M; Flørenes VA; Hansen TV
Bioorg Med Chem; 2008 May; 16(9):4829-38. PubMed ID: 18396050
[TBL] [Abstract][Full Text] [Related]
26. Structure-based virtual screening of novel tubulin inhibitors and their characterization as anti-mitotic agents.
Kim ND; Park ES; Kim YH; Moon SK; Lee SS; Ahn SK; Yu DY; No KT; Kim KH
Bioorg Med Chem; 2010 Oct; 18(19):7092-100. PubMed ID: 20810285
[TBL] [Abstract][Full Text] [Related]
27. Anticancer effects of the metabolic products of the resveratrol analogue, DMU-212: structural requirements for potency.
Androutsopoulos VP; Ruparelia KC; Papakyriakou A; Filippakis H; Tsatsakis AM; Spandidos DA
Eur J Med Chem; 2011 Jun; 46(6):2586-95. PubMed ID: 21497957
[TBL] [Abstract][Full Text] [Related]
28. Molecular analysis on the chemopreventive properties of resveratrol, a plant polyphenol microcomponent.
Latruffe N; Delmas D; Jannin B; Cherkaoui Malki M; Passilly-Degrace P; Berlot JP
Int J Mol Med; 2002 Dec; 10(6):755-60. PubMed ID: 12430003
[TBL] [Abstract][Full Text] [Related]
29. Novel imidazole-based combretastatin A-4 analogues: evaluation of their in vitro antitumor activity and molecular modeling study of their binding to the colchicine site of tubulin.
Bellina F; Cauteruccio S; Monti S; Rossi R
Bioorg Med Chem Lett; 2006 Nov; 16(22):5757-62. PubMed ID: 16950621
[TBL] [Abstract][Full Text] [Related]
30. Resveratrol inhibits cell cycle progression in U937 cells.
Castello L; Tessitore L
Oncol Rep; 2005 Jan; 13(1):133-7. PubMed ID: 15583814
[TBL] [Abstract][Full Text] [Related]
31. 3,5,3',4',5'-pentamethoxystilbene (MR-5), a synthetically methoxylated analogue of resveratrol, inhibits growth and induces G1 cell cycle arrest of human breast carcinoma MCF-7 cells.
Pan MH; Lin CL; Tsai JH; Ho CT; Chen WJ
J Agric Food Chem; 2010 Jan; 58(1):226-34. PubMed ID: 19916542
[TBL] [Abstract][Full Text] [Related]
32. Lead identification of conformationally restricted benzoxepin type combretastatin analogs: synthesis, antiproliferative activity, and tubulin effects.
Barrett I; Carr M; O'Boyle N; Greene LM; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ
J Enzyme Inhib Med Chem; 2010 Apr; 25(2):180-94. PubMed ID: 20222762
[TBL] [Abstract][Full Text] [Related]
33. New antitubulin derivatives in the combretastatin A4 series: synthesis and biological evaluation.
Borrel C; Thoret S; Cachet X; Guénard D; Tillequin F; Koch M; Michel S
Bioorg Med Chem; 2005 Jun; 13(11):3853-64. PubMed ID: 15863010
[TBL] [Abstract][Full Text] [Related]
34. Substituted trans-stilbenes, including analogues of the natural product resveratrol, inhibit the human tumor necrosis factor alpha-induced activation of transcription factor nuclear factor kappaB.
Heynekamp JJ; Weber WM; Hunsaker LA; Gonzales AM; Orlando RA; Deck LM; Jagt DL
J Med Chem; 2006 Nov; 49(24):7182-9. PubMed ID: 17125270
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological evaluation of cis-locked vinylogous combretastatin-A4 analogues: derivatives with a cyclopropyl-vinyl or a cyclopropyl-amide bridge.
Ty N; Kaffy J; Arrault A; Thoret S; Pontikis R; Dubois J; Morin-Allory L; Florent JC
Bioorg Med Chem Lett; 2009 Mar; 19(5):1318-22. PubMed ID: 19211248
[TBL] [Abstract][Full Text] [Related]
36. N-Phenyl-N'-(2-chloroethyl)urea analogues of combretastatin A-4: Is the N-phenyl-N'-(2-chloroethyl)urea pharmacophore mimicking the trimethoxy phenyl moiety?
Fortin S; Moreau E; Lacroix J; Teulade JC; Patenaude A; C-Gaudreault R
Bioorg Med Chem Lett; 2007 Apr; 17(7):2000-4. PubMed ID: 17291753
[TBL] [Abstract][Full Text] [Related]
37. Discovery of small molecule inhibitors that interact with γ-tubulin.
Friesen DE; Barakat KH; Semenchenko V; Perez-Pineiro R; Fenske BW; Mane J; Wishart DS; Tuszynski JA
Chem Biol Drug Des; 2012 May; 79(5):639-52. PubMed ID: 22268380
[TBL] [Abstract][Full Text] [Related]
38. Abilities of 3,4-diarylfuran-2-one analogs of combretastatin A-4 to inhibit both proliferation of tumor cell lines and growth of relevant tumors in nude mice.
Sun L; Vasilevich NI; Fuselier JA; Coy DH
Anticancer Res; 2004; 24(1):179-86. PubMed ID: 15015595
[TBL] [Abstract][Full Text] [Related]
39. Structure-based discovery of a boronic acid bioisostere of combretastatin A-4.
Kong Y; Grembecka J; Edler MC; Hamel E; Mooberry SL; Sabat M; Rieger J; Brown ML
Chem Biol; 2005 Sep; 12(9):1007-14. PubMed ID: 16183025
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of mammalian DNA polymerases by resveratrol: mechanism and structural determinants.
Locatelli GA; Savio M; Forti L; Shevelev I; Ramadan K; Stivala LA; Vannini V; Hübscher U; Spadari S; Maga G
Biochem J; 2005 Jul; 389(Pt 2):259-68. PubMed ID: 15773817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
